COVID-19 Vaccination Decision Guide for Pregnant and Breastfeeding Women

This document is a guide to COVID-19 vaccination for women who are pregnant, breastfeeding or planning pregnancy. It contains information about the Comirnaty vaccine, produced by Pfizer.


COVID-19 Vaccination Decision Guide for Pregnant and Breastfeeding Women - cover page
Category
Health Care
Document type
Other
Language
English
Pages
7
File format
PDF
File size
225 KB
Published
18 November, 2023
Updated
18 November, 2023
MD5 checksum
09BDA96D73E96DB452393CDCC3725F4C

About this manual

This document serves as a decision guide for women considering the COVID-19 vaccine Comirnaty (Pfizer, Australia) while pregnant, breastfeeding, or planning a pregnancy. It outlines the vaccine's mechanism, noting it is not a live vaccine and contains mRNA genetic code for the spike protein. The guide explains that two doses are required for best protection, administered at least three weeks apart.

What's inside

  • Introduction
  • COVID-19 vaccine
  • If you are breastfeeding
  • If you are planning pregnancy
  • If you are pregnant
  • Possible complications
  • Possible benefits
  • Possible harms
  • Factors to consider

Frequently asked questions

Can breastfeeding women receive the Comirnaty vaccine?

Yes, you can receive Comirnaty at any time while breastfeeding and do not need to stop breastfeeding before or after vaccination.

Is a pregnancy test required before getting vaccinated?

No, you are not required to have a pregnancy test before getting vaccinated.

What are the common side effects of the Comirnaty vaccine?

Common side effects include pain at the injection site (84%), tiredness (62%), headache (52%), muscle pain (37%), chills (35%), joint pain (22%), fever (16%), and diarrhoea (10%).

Download PDF (225 KB)

Also Manuals